Novartis agreed to pay about $390 million to settle kickback claims before the $3.3 billion case went to trial.
The allegations arose when the United States Department of Justice sued Novartis for illegally boosting sales of drugs covered by Medicare and Medicaid programs. Novartis used kickbacks to specialty pharmacies to push sales of some drugs.